http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009026501-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7317808024e524eea40a6c5a5ad6a22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L29-7783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-0883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L21-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L29-778
filingDate 2005-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32db68f77ea8673c63d12371403d4480
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eec0bf1ac01726a3f3e66dcca82c305
publicationDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009026501-A1
titleOfInvention Enhancement - depletion semiconductor structure and method for making it
abstract A ED-HEMT structure includes a buffer layer ( 4 ) including a doped layer ( 18 ), a channel layer ( 6 ), a barrier layer ( 8 ), and a second doped layer ( 20 ). An enhancement mode HEMT gate ( 12 ) is formed in a via extending through the second doped layer ( 20 ) and a depletion mode HEMT structure is formed over the second doped layer ( 20 ). The layer sequence allows the formation of both enhancement and depletion mode HEMTs in the same structure with good properties.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9679975-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9083334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023080772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011147845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10868125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013307091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11705334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11081355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019160598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013105910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10170610-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10734498-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I692875-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10714605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10418448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017340449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11404541-B2
priorityDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008296622-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6620662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6465815-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008001173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007278519-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511

Total number of triples: 43.